Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-02, Stock:JNJ, The news for the past five days is as follows:
2018-02-23: NEWS1: JNJ INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018.NEWS2: Stocks are coiling for the next big move.NEWS3: Pawar Law Group Announces That a Class Action Lawsuit Has Been Filed On Behalf of Shareholders Who Purchased Shares of Johnson & Johnson (NYSE: JNJ) Between February 22, 2013 and February 7, 2018, Both Dates Inclusive.NEWS4: Achillion (ACHN) Q4 Loss Widens, Plans Job Cuts to Save Cost.NEWS5: Achillion (ACHN) Q4 Loss Widens, Plans Job Cuts to Save Cost.NEWS6: How Johnson & Johnson’s Infectious Diseases Portfolio Perform in 2017.NEWS7: Can brands force fix of social media's problems?.NEWS8: Achillion (ACHN) Q4 Loss Widens, Plans Job Cuts to Save Cost.NEWS9: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 26, 2018.NEWS10: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 26, 2018.NEWS11: 3 Top Dividend Stocks With Yields Over 2%.NEWS12: 3 Top Dividend Stocks With Yields Over 2%.NEWS13: Johnson & Johnson’s Simponi Could See Steady Growth in 2018.NEWS14: Performance of Johnson & Johnson’s Remicade and Stelara in 2017.NEWS15: 3 Top Dividend Stocks With Yields Over 2%.NEWS16: Jim Cramer: You Have to Decide If You Want to Profit From This Moment.
2018-02-26: NEWS1: Why Achillion Pharmaceuticals, Inc. Stock Spiked Today.NEWS2: A Deeper Look at Alkermes’ Key Marketed Products.NEWS3: Johnson & Johnson’s Oncology Segment’s Performance in 2017.NEWS4: Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 27, 2018.NEWS5: Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 27, 2018.NEWS6: How JNJ’s Hypertension Segment Performed in 4Q17.NEWS7: Johnson & Johnson’s Neuroscience Segment in 2017.NEWS8: Medtronic's Dominance Results in Wide Moat.
2018-02-27: NEWS1: U.S. to seek reimbursement from opioid makers, distributors.NEWS2: DOJ to support lawsuits against companies selling opioids.NEWS3: The Klein Law Firm Announces a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018 (JNJ).NEWS4: TTOO Gains Steam, LPCN Up On Upgrade, ALDX Abuzz.NEWS5: TTOO Gains Steam, LPCN Up On Upgrade, ALDX Abuzz.NEWS6: JNJ INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Johnson & Johnson.NEWS7: Johnson & Johnson Poised to Move Higher, Buy Available Weakness.NEWS8: JNJ’s Cardiovascular Segment’s Performance in 4Q17 and 2017.NEWS9: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS10: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS11: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS12: How Did Johnson & Johnson’s Zytiga Perform in 2017?.NEWS13: Darzalex Could Boost JNJ’s Revenue Growth in 2018.NEWS14: [$$] Boost Biomes Launches with Seed Round for Sustainable Farming.NEWS15: Masonite adds health care, tech industry veterans to board of directors.NEWS16: Why Achillion Pharmaceuticals, Inc. Stock Spiked Today.NEWS17: Why Achillion Pharmaceuticals, Inc. Stock Spiked Today.
2018-02-28: NEWS1: Cramer's lightning round: Nokia has become a good spec. I'm done selling.NEWS2: MedTech&apos;s Long-Term Prospects Outweigh Near-Term Risks.NEWS3: J&J Shares Off to Worst Start to a Year This Century: RBC Capital Markets.NEWS4: Noteworthy ETF Inflows: IVV, JPM, JNJ, GOOG.NEWS5: Noteworthy ETF Inflows: IVV, JPM, JNJ, GOOG.NEWS6: The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018.NEWS7: Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific.NEWS8: Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific.NEWS9: Theravance Biopharma (TBPH) Q4 Loss Wider, Sales Drop Y/Y.NEWS10: Theravance Biopharma (TBPH) Q4 Loss Wider, Sales Drop Y/Y.NEWS11: SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline - April 9, 2018.NEWS12: Theravance Biopharma (TBPH) Q4 Loss Wider, Sales Drop Y/Y.NEWS13: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for March 01, 2018.NEWS14: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for March 01, 2018.NEWS15: Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific.NEWS16: Analysts’ Recommendations for Johnson & Johnson in February 2018.NEWS17: Medical Device Industry Outlook - February 2018.NEWS18: Medical Device Industry Outlook - February 2018.NEWS19: 3 Dividend Stocks That Are Minting Money.NEWS20: 3 Dividend Stocks That Are Minting Money.NEWS21: 3 Dividend Stocks That Are Minting Money.NEWS22: 10 Best Stocks to Buy and Hold Forever.NEWS23: 10 Best Stocks to Buy and Hold Forever.
2018-03-01: NEWS1: How Tax Cuts and Jobs Act Impacted Align’s 4Q17 Earnings.NEWS2: Making Sense of Twitter’s Audience Metrics.NEWS3: Jim Cramer Advises His Viewers On Johnson & Johnson, Nokia And More.NEWS4: Cramer's lightning round: Nokia has become a good spec. I....

Answer: Rise